caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1336209915

Stephan MollMD

Hematology-OncologyChapel Hill, NCI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Stephan Moll's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 4 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Blair Keagy
Vascular Surgery · Chapel Hill, NC
31114
Lisa Rose-Jones
Advanced Heart Failure and Transplant Cardiology · Wilmington, NC
1523
PARKER, LEONARD1228
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
UNIVERSITY OF NORTH CAROLINA HOSPITALS AT CHAPEL HILL95464
Blair Keagy
Vascular Surgery · Chapel Hill, NC
1780
Laboratory Corporation Of America Holdings
Clinical Laboratory · Burlington, NC
1432
Paula Miller
Cardiology · Chapel Hill, NC
1223
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
145
Unique beneficiaries
—
Total services
147
Distinct HCPCS
7
Medicare payment
$9K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 329 Hematology-Oncology providers in NC — bottom quintile (cohort median 605).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
371
Beneficiaries
—
Total drug cost
$402K
Distinct drugs
4
Brand share
86.8%
Top prescribed drugs
Apixaban233 claims
Rivaroxaban89 claims
Fondaparinux Sodium34 claims
Enoxaparin Sodium15 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.